首页 | 本学科首页   官方微博 | 高级检索  
     

β-阻滞剂治疗慢性充血性心力衰竭的临床进展
引用本文:叶挺梅. β-阻滞剂治疗慢性充血性心力衰竭的临床进展[J]. 丽水学院学报, 2007, 29(5): 55-58
作者姓名:叶挺梅
作者单位:丽水学院,科研管理与科技开发处,浙江,丽水,323000
摘    要:介绍了临床应用β-阻滞剂治疗慢性充血性心力衰竭(CHF)的发展.应用β-阻滞剂治疗CHF可显著改善临床症状,降低死亡率,特别是对特发性DCM的疗效最为显著.β-阻滞剂治疗CHF应当在病情稳定后开始使用.介绍了不同β-阻滞剂的作用特点以及具体应用方法,并针对可能发生的药物不良反应提出了防治方法.

关 键 词:β-阻滞剂  心力衰竭  药物治疗  病死率
文章编号:1008-6749(2007)05-0055-04
修稿时间:2007-06-25

Advances in the Beta-Blocker Therapy in Patients with Chronic Heart Failure
Ye Tingmei. Advances in the Beta-Blocker Therapy in Patients with Chronic Heart Failure[J]. Journal of Lishui University, 2007, 29(5): 55-58
Authors:Ye Tingmei
Affiliation:Department of Management and Exploition of Science and Technology,Lishui University,Lishui Zhejiang 323000,China
Abstract:The development of Beta blockers in the treatment for chronic congestive heart failure was reviewed.Beta blockers can improve the clinical symptoms and homodynamic data,decrease the mortalities in patients with CHF, especially to the patients with dilated cardiomyopathy(DCM).Beta blockers should be used until the patient conditions were stable.The characteristics of different beta blockers and the methods for the use as well as the management for the side effects of beta blockers that might happen after the treatment were introduced.
Keywords:Beta blockers  heart failure  drug therapy  mortality
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号